R&D

ASCA101 (Core Technology)

The main technology of Metafines , called ‘ASCA101’ is related to new pharmacological composition for cancer treatment. ‘ASCA101’ is metabolic anti-cancer drug that has excellent therapeutic effect by disrupting the metabolic processes of working cancer cells in duplicate and complex ways through different mechanisms are acted in each cancer cell due to simultaneous uptake of different compounds to cancer cells. And also, ‘ASCA101’ is less susceptible to drug resistance, which can more effectively inhibit the effects of cancer cells such as proliferation, infiltration, and metastasis.

  • ASCA101

  • Inducing Cytotoxicity,
    Apoptosis with
    Cancer Cell
    Selectivity

    Low-Toxic Drug
    Repositioning NCE

    Inducing Cytotoxicity,
    Apoptosis with
    Cancer Cell
    Selectivity

    Anti-cancer Drug of
    complex mechanism
    (ATP depletion,
    ROS increase)

    *NCE : New Chemical Entities